Imago Biosciences, Inc.
SEC CIK 1623715 · IMGO · last insider filing 2023-01-11
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Henner Dennis | Director | filed 2021 - 2023 |
| Baltera Robert Jr. | Director | filed 2021 - 2023 |
| Keating Laurie | Director | filed 2021 - 2023 |
| Chaya Moghrabi Dina | Director | filed 2021 - 2023 |
| Kariuki Enoch | Director | filed 2021 - 2023 |
| Rienhoff Hugh JR | Director · Chief Executive Officer | filed 2021 - 2023 |
| Heron Patrick J | Director | filed 2021 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Arenberg Michael | See Remarks | filed 2022 - 2023 |
| Peppe Jennifer | See Remarks | filed 2021 - 2023 |
| Eichorn Laura G. | See Remarks | filed 2021 - 2023 |
| Tapper Amy E. | See Remarks | filed 2021 - 2023 |
| Chiang Hsiangyi | Senior Vice President, Finance | filed 2022 - 2023 |
| Hong Wan-Jen | Chief Medical Officer | filed 2021 - 2022 |
| Plunkett Matthew | Chief Financial Officer | filed 2021 - 2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.